PMLiVE’s Top Pharma list has launched, ranking the top companies in the pharmaceutical industry by their global sales, as well as by their revenues in the US, Europe and Japan.
Each company listed has its own profile page, featuring graphs for each of the global revenue rankings, which include rankings for biologic, cardiovascular, central nervous system, immunology, metabolic, ophthalmology, respiratory and oncology sales.
The ranking of the top pharma companies has been compiled from GlobalData’s pharmaceutical revenue figures, which are based on sales of prescription medicines, including generics drugs. The rankings include historical data from 2006 to 2023 and forecast data for 2024 to 2030.
Top 25 Pharma Companies – Global sales
Johnson & Johnson has claimed the top spot on the list of Top 25 Pharma Companies based on Global sales. The company reported $54,103m in global revenue in 2023, with this predicted to grow to $58,941m in 2025 and $80,170m in 2030.
AbbVie and Merck & Co have taken second and third place in Global sales, respectively, with Roche, Pfizer, Novartis, Bristol Myers Squibb, AstraZeneca, Sanofi and GSK also making the top ten.
Read the article in full here.